PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsVonapanitase
Vonapanitase
Vonapanitase is an enzyme pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
41 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PancreatitisD010195EFO_0000278K85167
Diabetes mellitusD003920EFO_0000400E08-E13134
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic renal insufficiencyD051436N182325
Arteriovenous fistulaD001164Q27.31224
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Exocrine pancreatic insufficiencyD010188K86.811910
Chronic pancreatitisD050500EFO_0000342K86.1145
Acute lung injuryD055371EFO_00046101113
FibrosisD005355213
Type 2 diabetes mellitusD003924EFO_0001360E11112
Respiratory tract diseasesD012140112
Respiration disordersD012120J00-J99112
Graft vs host diseaseD006086D89.81222
BronchiectasisD001987J47112
FistulaD005402122
Show 14 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Peripheral arterial diseaseD058729EFO_000426533
Pathologic constrictionD00325122
Chronic limb-threatening ischemiaD00008980211
Intermittent claudicationD007383EFO_0003876I73.911
Lung injuryD055370S27.3011
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Covid-19D000086382U07.133
Pancreatic neoplasmsD010190EFO_0003860C2522
Metabolic syndromeD024821EFO_0000195E88.81022
SepsisD018805EFO_0001420A41.922
Body weightD001835EFO_000433811
Weight gainD01543011
Morbid obesityD009767EFO_000107411
HypertensionD006973EFO_0000537I1011
Respiratory insufficiencyD012131J96.911
Portal hypertensionD006975EFO_0000666K76.611
Show 20 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameVonapanitase
INNvonapanitase
Description
Vonapanitase is an enzyme pharmaceutical. It is currently being investigated in clinical studies.
Classification
Enzyme
Drug classenzymes
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL3545070
ChEBI ID
PubChem CID
DrugBank
UNII ID3LWJ2H14I9 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 355 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use